Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Onesource Specialty Pharma Ltd.
No Price
Closing Price XNSE 30.04.2026:
1.752,00 INR
30.04.2026 10:00
Current Prices from Onesource Specialty Pharma Ltd.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NSE
ONESOURCE.NS
INR
30.04.2026 10:00
1.752,00 INR
-
Share Float & Liquidity
Free Float51,84 %
Shares Float59,44 M
Shares Outstanding114,64 M
Company Profile for Onesource Specialty Pharma Ltd. Share
OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; soft gelatin capsules; and biologics solutions for microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and RNA products. The company was formerly known as Stelis Biopharma Limited and changed its name to OneSource Specialty Pharma Limited in February 2024. OneSource Specialty Pharma Limited was incorporated in 2007 and is based in Bengaluru, India.
